Abstract
Aims: The association between tissue factor (TF) expression and increased rate of tumour metastasis is well established. In this study, we have examined the hypothesis that the expression of TF by disseminated tumour cells confers protection against immune recognition and cytotoxicity. Materials and methods: A hybrid EGFP-TF protein was expressed in HT29 colon carcinoma and K562 lymphoblast cell lines. To assess the cytotoxic activity against tumour cells over-expressing TF, a novel method was used, based on the direct measurement of fluorescently labelled HT29 or K562 target cells. Results: Upon challenge with peripheral blood mononuclear cells (PBMC), tumour cells expressing TF partially evaded cellular cytotoxicity (Δ=15–40% reduction in cytotoxicity). Moreover, the influence of TF was not primarily dependent on its procoagulant function, although the inclusion of 20% (v/v) plasma did lower the rate of cytotoxicity against untransfected cells. However, expression of a truncated form of TF, devoid of the cytoplasmic domain, did not mediate any degree of inhibition of cytotoxicity, suggesting that the protective function of TF is principally due to this domain. Conclusions: We conclude that TF can promote immune evasion in tumour cells expressing this protein leading to increased survival and therefore metastatic rate in such cells.
Similar content being viewed by others
References
Kirchhofer D, Nemerson Y (1996) Initiation of blood coagulation: the tissue factor/factor VIIa complex. Curr Opin Biotechnol 7:386–391
Callander NS, Varki N, Rao LV (1992) Immunohistochemical identification of tissue factor in solid tumors. Cancer 70:1194–1201
Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RC (1995) Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 346:1004–1005
Koomagi R, Volm M (1998) Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 79:19–22
Lawleed BA, Chisholm M, Francis JL (1999) Urinary tissue factor levels in patients with breast and colorectal cancer. J Pathol 187:291–294
Vrana JA., Stang MT, Grande JP, Getz MJ (1996) Expression of tissue factor in tumour stroma correlates with progression to invasive human breast Cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 56:5063–5070
Ueda C, Hirohata Y, Kihara Y, Nakamura H, Abe S, Akahane K, Okamoto K, Itoh H, Otsuki M (2001) Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor. J Gastroenterol 36:845–850
Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y (1996) Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77:1877–1883
Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, Catalona WJ, Milbrandt J (2000) Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 31:443–447
Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, Nakamura S, Shiku H. (2002) Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 69:247–254
Shigenmori C, Wada H, Matsumoto K, Shioklu H, Nakamura S, Suzuki H (1998) Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemostas 80:894–898
Bierhaus A, Nawroth PP (2005) Coagulation, inflammation and immune response-an evolutionary conserved plan as cause for disseminated intravasal coagulation? Hamostaseologie 25:23–32
Dvora HF, Senger DR, Dvorak AM (1983) Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev 2:41–73
Bardos H, Molnar P, Csecsei G, Adany R (1996) Fibrin deposition in primary and metastatic human brain tumors. Blood Coagula Fibrinolysis 7:536–548
Wojtukiewicz MZ, Zacharaski LR, Memoli VA (1990) Fibrinogen-fibrin transformation in situ in renal cell carcinoma. Anticancer Res 10:579–582
Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirouskova M, Degen JL (2005) Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185
Gunji Y, Lewis J, Gorelik E (1990) Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells. Blood Coagul Fibrinolysis 1:663–672
Gorelik E (1992) Protective effect of fibrin on tumour metastasis. Fibrinolysis 6:35–38
Carr ME Jr, Sajer SA, Spaulding A (1992) Fibrin coating of bladder tumor cells (T24) is not protective against LAK cell cytotoxicity. J Lab Clin Med 119:132–138
Reijerkerk A, Meijers JC, Havik SR, Bouma BN, Voest EE, Gebbink MF (2004) Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice. J Thromb Haemost 2:769–779
Kunzelmann-Marche C, Satta N, Toti F, Zhang Y, Nawroth PP, Morrissey JH, Freyssinet JM. (2000) The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemost 83:282–289
Dietzen DJ, Jack GG, Page KL, Tetzloff TA, Hall CL, Mast AE. (2003) Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity. Thromb Haemost 89:65–73
Mulder AB, Smit JW, Bom VJ, Blom NR, Ruiters MH, Halie MR, van der Meer J. (1996) Association of smooth muscle cell tissue factor with caveolae. Blood 88:1306–1313
Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159–211
Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, Wilcox JN, Danave I, Dillehay DL, Matthews E, Contrino J, Morrissey JH, Gordon S, Edgington TS, Kudryk B, Kreutzer DL, Rickles FR (1998) Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 152:399–411
Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP (1994) Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94:1320–1327
Mueller B, Ruf W (1998) Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 101:1372–1378
Contrino J, Hair G, Kreutzer DL, Rickles FR (1996) In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 2:209–215
Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigsberg WH (1999) Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 82:88–92
Versteeg HH, Richel DJ, Peppelenbosch MP, Spek CA (2004) Concerted action of coagulation factors on cell survival. J Thromb Haemost 2:673–674
Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A (1995) Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 92:8205–8209
Brunner KT, Mauel J, Cerottini JC, Chapuis B (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181–196
Brown CE, Wright CL, Naranjo A, Vishwanath RP, Chang WC, Olivares S, Wagner JR, Bruins L, Raubitschek A, Cooper LJ, Jensen MC (2005) Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing. J Immunol Methods 297:39–52
Sorensen BB, Rao LV, Tornehave D, Gammeltoft S, Petersen LC (2003) Antiapoptotic effect of coagulation factor VIIa. Blood 102:1708–1715
Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, Casper K, Dillehay DL, Nawroth PP, Rickles FR (1999) Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 96:8663–8668
Versteeg HH, Peppelenbosch MP, Spek CA (2003) Tissue factor signal transduction in angiogenesis. Carcinogenesis 24:1009–1013
Paborsky LR, Tate KM, Harris RJ, Yansura DG, Band L, McCray G, Gorman CM, O’Brien DP, Chang JY, Swartz JR, Fung VP, Thomas JN, Vehar GA (1989) Purification of recombinant human tissue factor. Biochemistry 28:8072–8077
Paborsky LR, Caras IW, Fisher KL, Gorman CM (1991) Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J Biol Chem 266:21911–21916
Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10:502–509
Pawlinski R, Pedersen B, Erlich J, Mackman N (2004) Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice. Thromb Haemostas 92:444–450
Watanabe T, Yasuda M, Yamamoto T (1999) Angiogenesis induced by tissue factor in vitro and in vivo. Thrombosis Res 96:183–189
James NJ, Ettelaie C, Bruckdorfer KR (2002) Inhibition of tissue factor activity reduces the density of cellular network formation in an in vitro model of angiogenesis. Biochem Soc Trans 30:217–221
Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H (2000) Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 275:6580–6585
Poulsen LK, Jacobsen N, Sorensen BB, Bergenhem NC, Kelly JD, Foster DC, Thastrup O, Ezban M, Petersen LC (1998) Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 273:6228–6232
Hartzell S, Ryder K, Lanahan A, Lau LF, Nathan D (1989) A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol 9:2567–2573
Versteeg HH, Spek CA, Peppelenbosch MP, Richel DJ (2004) Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med 10:6–11
Versteeg HH, Spek CA, Richel DJ, Peppelenbosch MP (2004) Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene 23:410–417
Versteeg HH, Spek CA, Slofstra SH, Diks SH, Richel DJ, Peppelenbosch MP (2004) FVIIa: TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ Res 94:1032–1040
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, C., Colman, L.M., Collier, M.E.W. et al. Tumour-expressed tissue factor inhibits cellular cytotoxicity. Cancer Immunol Immunother 55, 1301–1308 (2006). https://doi.org/10.1007/s00262-006-0130-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-006-0130-1